ACTRN12616000589482
Completed
Not Applicable
The investigation of the effects of extracorporeal shock wave therapy (ESWT) and kinesiotherapy (KIN) on health status of women with bilateral knee osteoarthritis (OA): a randomised trial
Holycross College0 sites60 target enrollmentMay 6, 2016
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- knee pain
- Sponsor
- Holycross College
- Enrollment
- 60
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •female gender, minimum age of 40, ability to perform physical exercises, not currently receiving any physical therapy treatments for the knee OA condition, medication compliance (all patients were taking glucocorticoids at the time of the study), and the diagnosis of bilateral knee OA according to the American College of Rheumatology criteria
Exclusion Criteria
- •unilateral knee OA, neurological disorders, cognitive limitations or history of cardiovascular, pulmonary or endocrinology disease
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
A comparative study of shock wave therapy and corticosteroid injection in the treatment of heel paiplantar fasciitis.Fibroblastic disordersIRCT201203069221N1Army University of Medical Sciences74
Not yet recruiting
Phase 1
Clinical study on the application of extracorporeal shock wave in the treatment of early and middle stage knee osteoarthritis based on the meridian sinew theoryknee osteoarthritisITMCTR2100005479The Third Medical Center of Chinese People's Liberation Army General Hospital
Completed
Phase 3
Shock wave therapy for treatment of chronic achilles tendinopathy.IRCT2016051727907N1vice chancellor for research, Isfahan University of Medical Sciences40
Active, not recruiting
Phase 1
A clinical study in patients with moderate to severe graft-versus-host disease, patients randomly assigned to standard of care or to standard of care plus Extracorporeal (ECP) Therapy with UVADEX™EUCTR2010-022780-35-HUTHERAKOS, Inc.60
Active, not recruiting
Not Applicable
A clinical study in patients with moderate to severe graft-versus-host disease, patients randomly assigned to standard of care or to standard of care plus Extracorporeal (ECP) Therapy with UVADEX™Chronic graft-versus-host disease (cGvHD)MedDRA version: 14.1Level: PTClassification code 10018651Term: Graft versus host diseaseSystem Organ Class: 10021428 - Immune system disordersTherapeutic area: Diseases [C] - Immune System Diseases [C20]EUCTR2010-022780-35-ITTHERAKOS60